Back

prof. dr. A.C.G. (Toine) Egberts

prof. dr. A.C.G. (Toine) Egberts

Full Professor
prof. dr. A.C.G. (Toine) Egberts
  • Clinical Pharmacy

Biography

Biography

Toine Egberts (1965) obtained his PharmD in 1990 at the University of Groningen, the Netherlands. Thereafter he was trained as a clinical pharmacist during four years in the hospitals of Tilburg and Delft. In 1994, he started his PhD project at the department of Pharmacoepidemiology & Clinical Pharmacology of Utrecht University in collaboration with the Netherlands Pharmacovigilance Foundation 'Lareb'. This resulted in 1997 in a thesis entitled 'Pharmacoepidemiologic approaches to the evaluation of antidepressant drugs'. During his PhD-project he obtained the Master of Science degree in clinical epidemiology at the Netherlands Institute of Health Sciences.

He was appointed in 2001 as professor of clinical pharmacoepidemiology at the department of Pharmacoepidemiology & Clinical Pharmacology. Since 2006 he is also a professor of clinical pharmacy at the medical faculty of Utrecht University. In these positions he tries to bridge the drug environment and the patient environment.

From 2006 - 2017 he was the chief pharmacist of the department of clinical pharmacy of the University Medical Center Utrecht.

Since november 2018 he is director of doctor education of the Graduate School of Life Sciences of the Utrecht University. The coaching of PhD students gives him energy as it nicely balances performing research into medical/pharmaceutical puzzles with the personal development of young academic professionals. He had the opportunity to guide over 60 PhD students towards the 'hora est'. He has always been deeply involved in education, especially the training of hospital pharmacists, for which he received in 2016 the 'Senior Jan Glerum Award'.

He is (co)author of over 450 international peer reviewed scientific publications and a reviewer for several scientific journals and international research funding organisations.

He is a member of the editorial board of the journal Drug Safety. He is member of several committees such as the CCMO, the Netherlands Expertcenter for Pharmacotherapy for older people (EPHOR), the scientific advisory board of the Mental Health Center of the University of Wurzburg.

His research activities focus on a) the clinical pharmacology / clinical pharmacoepidemiology of drugs used in the treatment of psychiatric and neurologic disorders, and b) on innovations in clinical pharmacy systems.

He is married to Karin, has two daughters (Bibi and Louisa) and one son (Kilian) and in his spare time he likes to (trail)run, bootcamp, climb mountains and to play / listen to music.

Side Activities

All mentioned activities are current:

  • professor of clinical pharmacy, department of pharmaceutical sciences Utrecht University
  • director of doctoral education Graduate School of Life Sciences Utrecht University
  • member Centrale Commissie Mensgebonden Onderzoek (CCMO)
  • advisor clinical pharmacology group Jeroen Bossch Ziekenhuizen
  • member advisory board Dutch Association Hospital Pharmacists NVZA
  • member advisory board Utrecht Centre for Affordable Biotherapeutics (UCAB)
  • member supervisory board SIR Institure for Pharmacy Practice and Policy
  • reviewer of project proposals for funding organizsations such as ZonMw
  • member of the editorial board of the journal Drug Safety
  • reviewer for several other biomedical journals
  • board member of the Netherlands Expertcenter for Pharmacotherapy for older people (EPHOR)
  • member scientific advisory board Zentrum fur Psychische Gesundheit, Uniklinikum Wurzburg, Germany

Fellowship and Awards

Huizinga Penning (2004)

Senior Jan Glerum prijs (2016)

Research Output (531)

Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

Bognàr Tim, Bartelink Imke H, Egberts Toine C G, Rademaker Carin M A, Versluys A Birgitta, Slatter Mary A, Kletzel Morris, Nath Christa E, Cuvelier Geoffrey D E, Savic Rada M, Dvorak Christopher, Long-Boyle Janel R, Cowan Morton J, Bittencourt Henrique, Bredius Robbert G M, Güngör Tayfun, Shaw Peter J, Ansari Marc, Hassan Moustapha, Krajinovic Maja, Hempel Georg, Marktel Sarah, Chiesa Robert, Théoret Yves, Lund Troy, Orchard Paul J, Wynn Robert F, Boelens Jaap Jan, Lalmohamed Arief Apr 2022, In: Transplantation and Cellular Therapy. 28 , p. 196-202 7 p.

Impulse control disorders associated with dopaminergic drugs:A disproportionality analysis using vigibase

De Wit Laura E, Wilting Ingeborg, Souverein Patrick C, van der Pol Peggy, Egberts Toine C G Feb 2022, In: European Neuropsychopharmacology. 58 , p. 30-38 9 p.

Patients Retransitioning from Biosimilar TNF alpha Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review:A Systematic Review

Meijboom Rosanne W, Gardarsdottir Helga, Egberts Toine C G, Giezen Thijs J 6 Dec 2021, In: BioDrugs. 36 , p. 27-39 13 p.

Abstracts of the 17th Congress of the European Geriatric Medicine Society Live from Athens and Online, 11-13 October 2021

Noorda Nikki, Sallevelt Bastiaan, Egberts Toine, Puijenbroek Eugene van, Wilting I, Knol Wilma Dec 2021, p. 1-387 387 p.

The effect of the anticholinergic burden on duration and severity of delirium in older hip-surgery patients with and without haloperidol prophylaxis:A post hoc analysis

Tillemans Monique P H, Butterhoff-Terlingen Madelon H, Stuffken Rutger, Vreeswijk Ralph, Egberts Toine C G, Kalisvaart Kees J Dec 2021, In: Brain and Behavior. 11

Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity:A Genome-Wide Approach and Validation Study

Zazuli Zulfan, de Jong Corine, Xu Wei, Vijverberg Susanne J H, Masereeuw Rosalinde, Patel Devalben, Mirshams Maryam, Khan Khaleeq, Cheng Dangxiao, Ordonez-Perez Bayardo, Huang Shaohui, Spreafico Anna, Hansen Aaron R, Goldstein David P, de Almeida John R, Bratman Scott V, Hope Andrew, Knox Jennifer J, Wong Rebecca K S, Darling Gail E, Kitchlu Abhijat, van Haarlem Simone W A, van der Meer Femke, van Lindert Anne S R, Ten Heuvel Alexandra, Brouwer Jan, Ross Colin J D, Carleton Bruce C, Egberts Toine C G, Herder Gerarda J M, Deneer Vera H M, Maitland-van der Zee Anke H, Liu Geoffrey 20 Nov 2021, In: Journal of Personalized Medicine. 11 , p. 1-19

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept

Meijboom Rosanne W, Gardarsdottir Helga, Becker Matthijs L, Ten Wolde Saskia, Egberts Toine C G, Giezen Thijs J Nov 2021, In: BioDrugs. 35 , p. 765-772 8 p.

Safety profile of chloroquine and hydroxychloroquine:a disproportionality analysis of the FDA Adverse Event Reporting System database

Papazisis G, Siafis S, Cepatyte D, Giannis D, Stamoula E, Tzachanis D, Egberts T Oct 2021, In: European review for medical and pharmacological sciences. 25 , p. 6003-6012 10 p.

Switching TNF alpha inhibitors: Patterns and determinants:Patterns and determinants

Meijboom Rosanne W, Gardarsdottir Helga, Becker Matthijs L, de Groot Mark C H, Movig Kris L L, Kuijvenhoven Johan, Egberts Toine C G, Leufkens Hubert G M, Giezen Thijs J Aug 2021, In: Pharmacology research & perspectives. 9 , p. 1-9

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet